Ocular diseases impact not only health care spending in the ophthalmologist’s office, but also patients’ productivity and quality of life. This study by Paudel and colleagues found that across 3 countries, productivity costs and the value of quality of life lost were very important to the overall economic impact of late-stage age-related macular degeneration (AMD), even greater than the direct medical costs associated with treating this condition.
Leave a Reply